Andrew Linstead

Andrew Linstead began their work experience in 1989 at M.J.Allen as an Engineering Buyer, where they quickly advanced to lead their own buying team. In 2000, they joined Kent Pharma UK Ltd as a Senior Generic Buyer, managing stock and negotiating exclusivity contracts. In 2012, Linstead became the Head of Generics at Waymade Healthcare plc, responsible for expanding and developing their own label range of products. Most recently, in 2022, they joined Nordic Pharma as the Commercial Projects Director, where they focus on late-phase chemical entities, niche products, and company growth through various strategies.

Andrew Linstead pursued their B.Sc. (Honours) degree in Natural Sciences (Physics) from The Open University from 2013 to 2019.